News | July 17, 2009

AMPLATZER Vascular Plug 4 Received CE Mark

July 17, 2009 – AGA Medical Corp. received European CE mark approval for its AMPLATZER vascular plug, AVP 4, which is indicated for arterial and venous embolizations in the peripheral vasculature.

The device uses AMPLATZER’s proven mesh-braided nitinol technology and may eliminate the need for a catheter exchange, giving physicians a more efficient procedure, the company said. AGA Medical will begin marketing the AVP 4 in Europe immediately.

With its low profile, the AVP 4 allows delivery through a standard 0.038 diagnostic catheter. Physicians use one AVP 4 instead of multiple coil implants. A single device solution for peripheral embolization, the AVP 4 extends the AMPLATZER vascular plug family to smaller and often more distal vasculature. The device’s multilayered, double-lobed design provides rapid embolization. The flexible mesh and floppy distal section of the delivery wire facilitate easy tracking through torturous anatomy as well. AGA offers the AVP 4 in diameters ranging from 4 mm to 8 mm.

For more information: www.amplatzer.com


Related Content

News | Peripheral Artery Disease (PAD)

March 20, 2024 — Biotronik has been granted Breakthrough Device Designation (BDD) from the US Food and Drug ...

Home March 20, 2024
Home
News | Peripheral Artery Disease (PAD)

February 12, 2024 — Sensome, a company pioneering the connected medical device revolution with the world’s smallest ...

Home February 12, 2024
Home
News | Peripheral Artery Disease (PAD)

November 10, 2023 —Getinge announced commercial availability of the iCast covered stent system in the United States for ...

Home November 10, 2023
Home
News | Peripheral Artery Disease (PAD)

October 24, 2023 — Four years ago, following a publication based on the limited data available, the U.S. Food and Drug ...

Home October 24, 2023
Home
News | Peripheral Artery Disease (PAD)

September 14, 2023 — LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of ...

Home September 14, 2023
Home
News | Peripheral Artery Disease (PAD)

July 11, 2023 — The U.S. Food and Drug Administration (FDA) is informing healthcare providers about updated information ...

Home July 11, 2023
Home
News | Peripheral Artery Disease (PAD)

June 21, 2023 — A new science report issued by the American Heart Association (AHA) emphasizes the importance of ...

Home June 21, 2023
Home
News | Peripheral Artery Disease (PAD)

June 16, 2023 — Endologix LLC, a privately held, global medical device company, dedicated to providing disruptive ...

Home June 16, 2023
Home
News | Peripheral Artery Disease (PAD)

June 15, 2023 — Endologix LLC, a privately held, global medical device company dedicated to providing disruptive ...

Home June 15, 2023
Home
News | Peripheral Artery Disease (PAD)

March 8, 2023 — Treatments for peripheral artery disease (PAD) were largely developed in men and are less effective in ...

Home March 08, 2023
Home
Subscribe Now